EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Antiepileptic Drug Combinations for Epilepsy: Mechanisms, Clinical Strategies, and Future Prospects

Cunjiang Li, Xingyu Wang, Mingzhenlong Deng, Qinggen Luo, Chaoxing Yang, Zhicheng Gu, Shuxian Lin, Yongxiang Luo, Lei Chen, Yan Li, Bin He

International Journal of Molecular Sciences · 24.04.2025 · 26 (9) · 4035

DOI: 10.3390/ijms26094035 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.04.2025. Verfasst von Cunjiang Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Med…. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guizhou Science and Technology Department of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epilepsy is a chronic neurological disorder characterized by abnormal neuronal discharge, leading to recurrent and unpredictable disruptions in brain function. Despite over 30 antiepileptic drugs (AEDs), 30% of patients develop drug-resistant epilepsy, requiring combination therapy. This review explores epilepsy’s pathogenesis, including neuronal hyperexcitability, neurotransmitter imbalances, and ion channel dysfunction, alongside genetic, inflammatory, immune, and oxidative stress factors. AEDs are classified by mechanisms like voltage-gated ion channel modulation and GABA/glutamate regulation, tracing their evolution from traditional (e.g., phenobarbital) to modern therapies (e.g., lamotrigine). Combination therapy, using complementary mechanisms (e.g., lacosamide with levetiracetam), enhances efficacy but poses risks like drug interactions and cognitive impairment. Integrating molecular biology and pharmacology advances, this review highlights the need for rational drug selection and individualized strategies to improve epilepsy treatment outcomes and patient quality of life. Future directions include personalized treatments, optimized dosage forms, novel drug targets, and multi-target drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnticonvulsantsEpilepsyHumansDrug Therapy, CombinationAnimalsDrug Combinations

Stichwörter der Autor:innen

antiepileptic drugs (AEDs)combination therapydrug synergyepilepsymulti-target drugsprecision medicine

Substanzen

AnticonvulsantsDrug Combinations

Autor:innen und Institutionen

  • State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Provincial Key Laborato…
  • School of Basic Medical Science, Guizhou Medical University, Guiyang 550004, China.

Förderung

  • Guizhou Science and Technology Department of China

Zitieren

APA

Li, C., Wang, X., Deng, M., Luo, Q., Yang, C., Gu, Z., Lin, S., Luo, Y., Chen, L., Li, Y., & He, B. (2025). Antiepileptic Drug Combinations for Epilepsy: Mechanisms, Clinical Strategies, and Future Prospects. International Journal of Molecular Sciences, 26(9), 4035. https://doi.org/10.3390/ijms26094035

Vancouver

Li C, Wang X, Deng M, Luo Q, Yang C, Gu Z, et al. Antiepileptic Drug Combinations for Epilepsy: Mechanisms, Clinical Strategies, and Future Prospects. International Journal of Molecular Sciences. 2025;26(9):4035. doi:10.3390/ijms26094035

BibTeX
@article{Li2025,
  author = {Li, Cunjiang and Wang, Xingyu and Deng, Mingzhenlong and Luo, Qinggen and Yang, Chaoxing and Gu, Zhicheng and Lin, Shuxian and Luo, Yongxiang and Chen, Lei and Li, Yan and He, Bin},
  title = {Antiepileptic Drug Combinations for Epilepsy: Mechanisms, Clinical Strategies, and Future Prospects},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {9},
  pages = {4035},
  doi = {10.3390/ijms26094035}
}
Kostenlos starten →